{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:45:30Z","timestamp":1789623930620,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,10]],"date-time":"2026-12-10T00:00:00Z","timestamp":1796860800000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K23HL13992"],"award-info":[{"award-number":["K23HL13992"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaip.2025.09.020","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:04:16Z","timestamp":1758704656000},"page":"3316-3323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-World Adherence to Biologic Therapy for Severe Asthma in Children"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0083-5945","authenticated-orcid":false,"given":"Steven J.","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisaku","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Monir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa W.","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle R.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.09.020_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.09.020_bib4","first-page":"848","article-title":"Economic burden of illness among patients with severe asthma in a managed care setting","volume":"22","author":"Chastek","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jaip.2025.09.020_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105919","article-title":"Multinational cohort study of mortality in patients with asthma and severe asthma","volume":"165","author":"Engelkes","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.09.020_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ACI.0b013e3283292207","article-title":"Asthma and ethnic minorities: socioeconomic status and beyond","volume":"9","author":"Forno","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.020_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.09.020_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.09.020_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.alit.2018.11.007","article-title":"Severe asthma in children: evaluation and management","volume":"68","author":"Haktanir Abul","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.09.020_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fped.2018.00432","article-title":"New drugs for pediatric asthma","volume":"6","author":"Maglione","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2025.09.020_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/ped.2018.0901","article-title":"Current state and future of biologic therapies in the treatment of asthma in children","volume":"31","author":"Abrams","year":"2018","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.jaip.2025.09.020_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/jpm12060999","article-title":"Biologic therapies in pediatric asthma","volume":"12","author":"Perikleous","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaip.2025.09.020_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02420-2019","article-title":"Mepolizumab effectiveness and identification of super-responders in severe asthma","volume":"55","author":"Harvey","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.09.020_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chest.2020.08.2083","article-title":"Real-world effectiveness of benralizumab in severe eosinophilic asthma","volume":"159","author":"Kavanagh","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.09.020_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cea.13614","article-title":"Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort","volume":"50","author":"Dupin","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.09.020_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.alit.2022.11.008","article-title":"Biologics for severe asthma: the real-world evidence, effectiveness of switching, and prediction factors for the efficacy","volume":"72","author":"Nagase","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.09.020_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.jaip.2025.09.020_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2025.09.020_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ppul.25838","article-title":"Features of successful interventions to improve adherence to inhaled corticosteroids in children with asthma: a narrative systematic review","volume":"57","author":"Pearce","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2025.09.020_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fped.2018.00232","article-title":"Interventions on adherence to treatment in children with severe asthma: a systematic review","volume":"6","author":"Boutopoulou","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2025.09.020_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.chest.2020.10.050","article-title":"Adherence to asthma biologics: implications for patient selection, step therapy, and outcomes","volume":"159","author":"Maddux","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.09.020_bib22","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jaip.2022.05.022","article-title":"Factors related to biologic adherence and outcomes among moderate-to-severe asthma patients","volume":"10","author":"Osazuwa-Peters","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.020_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.anai.2023.07.017","article-title":"Real-world severe asthma biologic administration and adherence differs by biologic: CHRONICLE study results","volume":"131","author":"Ledford","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.09.020_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.020_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.anai.2022.01.018","article-title":"Adherence to inhaled corticosteroids prescribed once vs twice daily in children with asthma","volume":"128","author":"Drouin","year":"2022","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:07:23Z","timestamp":1778893643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825009146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213219825009146"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.020","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Adherence to Biologic Therapy for Severe Asthma in Children","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}